is a fast-flow, congenital vascular anomaly that is locally destructive and characterized by abnormal connections between arteries and veins. We previously reported that whole tissue specimens from patients with AVM lesions contain somatic mutations in MAP2K1 (K57N and Q56P) . The purpose of this study was to determine which tissue types in AVM contain MAP2K1 mutations.
INTRODUCTION:
Parry Romberg syndrome is a complex clinical entity characterized by progressive hemifacial atrophy. The differential diagnosis includes generalized scleroderma, morphea and CREST syndrome. These skin and soft tissue disorders are associated with polymorphic alleles of the HLA system. Thus, scleroderma is associated with HLA DR*11, CREST syndrome with HLA-DR*03, HLA-DR*01, while morphea does not have a direct association at least in mestizo population.
OBJECTIVE:
The purpose of this paper was to explore the potential association between Parry Romberg syndrome and alleles of the HLA system, in order to understand the physiopathogenic mechanism and the role of ethnicity in the development of the disease in mestizo individuals. We proposed an immunogenetic characterization of the disease, a research area not explored before globally in these patients.
MATERIAL AND METHODS:
We included 24 patients with Parry Romberg Syndrome from the Plastic and Reconstructive Surgery Department at Hospital General "Dr. Manuel Gea Gonzalez" in Mexico City. The diagnosis was based upon clinical examination, imaging and skin histopathology studies. The haplotypes of HLA involving HLA loci A, B, DR, DQ antigens were typified in 24 patients (48 haplotypes) and the frequencies were further established. The results were compared with frequencies from a group of 99 Mexican Mestizo patient controls without history of autoimmune or metabolic disease. The differences in gene frequencies were analyzed using nonparametric statistics that included Chi square test and Fisher's exact test, besides determining OR (odds ratio) and confidence intervals of 95%.
RESULTS:
Patients with Parry Romberg syndrome showed a significant increase in HLA-DRB1*16 (g.f: 14% PRS vs 1% in normal p=0.002; OR: 6.5, 95% CI. (1.9 -21.7) and diminished HLA-DR*07 (p=0.03; OR: 0.17, CI 95% 0.02 -1.2). Furthermore, it was found that the HLA-DR*16 is part of the haplotypes: HLA-DRB1*16 / DQB1*0301, in combination with HLA-B*39, HLA-B*15 alleles and HLA-B*35, in contrast with normal population which showed the HLA-DQB1*0502 allele DISCUSSION: Our research group has performed several HLA studies in the past, mainly in the organ transplantation and autoinmmune diseases scenarios. We have found that immunogenetic studies provide important data to understand the nature of diseases and establish medical and surgical treatment protocols. Data obtained from this study suggest that the haplotype HLA-DRB1*16 / HLA-DQB1*0301 confers susceptibility to Parry Romberg Syndrome. This haplotype has an indigenous origin, which suggests that mexican mestizo population with the syndrome, are influenced by the genetic background of the Native American. Also, since the risk alleles (HLA-DR*11, HLA-DR*01 and HLA-DR*03) for diseases traditionally related to the syndrome, were actually found diminished in this study, it suggests that Parry Romberg Syndrome is an entirely different entity, as proved by HLA studies.
CONCLUSION:
The haplotype HLA-DRB1*16 / HLA-DQB1*0301 confers susceptibility to Parry Romberg Syndrome in mestizo population. To our best knowledge, this is the first genetic study with this characteristics performed worldwide in patients with this syndrome. BACKGROUND: Venous outflow remains a leading cause of flap failure in DIEP breast reconstruction, but although venous compromise is multifactorial, the physiology of venous outflow is still poorly understood. The incidence of venous congestion has ranged from 3-27%. Near-infra red Laser-assisted Fluorescence angiography has gained popularity as an adjunct in breast reconstruction intra-operatively for assessment of flap arterial perfusion following flap harvest. We present our preliminary experience to highlight the use of this technology for intra-operative assessment of venous outflow in hemi-DIEP flaps.
Novel Assessment of Intra-Operative

METHODS:
Ten hemi-DIEP flaps were prospectively assessed intra-operatively following flap harvest, prior to the start of ischemia time. All flaps were raised on a single dominant perforator only. Imaging capture following peripheral injection of indocyanine green was recorded to assess both the arterial and venous phases of flap perfusion. Data was independently reviewed to comprehensively assess venous outflow patterns and rates of egress flap in the entire flap using updated software tools. Procedural notes and postoperative complications were collected through a chart review.
RESULTS: 10 hemi-DIEP flaps were assessed using a standardized intra-operative protocol following dissection of the perforator, and prior to transfer. Three flaps demonstrated venous washout concentrated solely around the dominant perforator of the deep system only, with adequate outflow in less than 30% of the entire flap. This was clinically recognized following flap transfer and venous augmentation with a superficial vein was carried out emergently. The remaining flaps showed a broad gradient of perfusion throughout the flap, which may indicate greater network of linking vessels, similar to arterial perfusion. Venous maps expressed greater correlation with arterial timing perfusion maps rather than intensity perfusion, which are currently used for intra-operative arterial assessment.
CONCLUSION:
Limited data exists on assessing venous outflow following anastomosis, yet nothing to our knowledge on venous assessment of flaps prior to transfer. This study is an on-going prospective investigation. Information can be ascertained intra-operatively prior to ischemia time to provide a comprehensive evaluation real-time of venous perfusion in the flap and subtlety in changes within flap regions that may provide early indications for venous augmentation. Further research is required to gain a better understanding of venous physiology and correlation with complications including unrecognized intra-operative venous congestion or fat necrosis.
